Arch Therapeutics, Inc.

New Filing

CIK: 0001537561·Biotechnology·NEVADA·Filed: Feb 25, 2021

Total Offering

$7,520,000

Amount Sold

$6,900,000

Investors

9

First Sale

Feb 11, 2021

Offering Details

Type: Equity, Option to Acquire, Security to be Acquired
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Terrence W. Norchi	Related Person
Punit Dhillon	Related Person
James R. Sulat	Related Person
Richard E. Davis	Related Person

Company

Arch Therapeutics, Inc.

235 WALNUT STREET, SUITE 6

FRAMINGHAM, MA, 01702

617-431-2313

SEC Filing

0000905718-21-000315

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.